Cargando…

Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin

Hemoglobin (Hb) modifiers that stereospecifically inhibit sickle hemoglobin polymer formation and/or allosterically increase Hb affinity for oxygen have been shown to prevent the primary pathophysiology of sickle cell disease (SCD), specifically, Hb polymerization and red blood cell sickling. Severa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omar, Abdelsattar M., Mahran, Mona A., Ghatge, Mohini S., Bamane, Faida H. A., Ahmed, Mostafa H., El-Araby, Moustafa E., Abdulmalik, Osheiza, Safo, Martin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453642/ https://www.ncbi.nlm.nih.gov/pubmed/27529207 http://dx.doi.org/10.3390/molecules21081057

Ejemplares similares

An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling
por: Omar, Abdelsattar M., et al.
Publicado: (2020)

Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents
por: Omar, A. M., et al.
Publicado: (2019)

Design, Synthesis, and Antisickling Investigation of a Thiazolidine Prodrug of TD-7 That Prolongs the Duration of Action of Antisickling Aromatic Aldehyde
por: Alhashimi, Rana T., et al.
Publicado: (2023)

Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease
por: El-Araby, Moustafa E., et al.
Publicado: (2020)

1H-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease
por: Omar, Abdelsattar M., et al.
Publicado: (2020)

Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin. Corrigendum
por: Abdulmalik, Osheiza, et al.
Publicado: (2011)

VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions
por: Abdulmalik, Osheiza, et al.
Publicado: (2020)

Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease
por: Huang, Boshi, et al.
Publicado: (2022)

Improving the Solubility and Oral Bioavailability of a Novel Aromatic Aldehyde Antisickling Agent (PP10) for the Treatment of Sickle Cell Disease
por: Ahmed, Tarek A., et al.
Publicado: (2021)

Clinical Implications of the Association of Fetal Hemoglobin with Peripheral Oxygen Saturation in Sickle Cell Disease
por: Abdulmalik, Osheiza, et al.
Publicado: (2017)

Molecular insight into 2-phosphoglycolate activation of the phosphatase activity of bisphosphoglycerate mutase
por: Aljahdali, Anfal S., et al.
Publicado: (2022)

Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease
por: Alhashimi, Rana T., et al.
Publicado: (2022)

Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia
por: Abdulmalik, Osheiza, et al.
Publicado: (2021)

Expression characterization of the herbicide tolerance gene Aryloxyalkanoate Dioxygenase (aad-1) controlled by seven combinations of regulatory elements
por: Gonzalez, Delkin O., et al.
Publicado: (2018)

Elucidating the Interaction between Pyridoxine 5′-Phosphate Oxidase and Dopa Decarboxylase: Activation of B6-Dependent Enzyme
por: AL Mughram, Mohammed H., et al.
Publicado: (2022)

A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells
por: Nakagawa, Akito, et al.
Publicado: (2018)

Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities
por: Alramadhani, Dina, et al.
Publicado: (2022)

Identification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte Sickling
por: Nakagawa, Akito, et al.
Publicado: (2014)

Inactive mutants of human pyridoxine 5′‐phosphate oxidase: a possible role for a noncatalytic pyridoxal 5′‐phosphate tight binding site
por: Ghatge, Mohini S., et al.
Publicado: (2016)

Design, Synthesis and in Vivo Anti-inflammatory Activities of 2,4-Diaryl-5-4H-imidazolone Derivatives
por: El-Araby, Moustafa, et al.
Publicado: (2012)

Modulation of hemoglobin dynamics by an allosteric effector
por: Lal, Jyotsana, et al.
Publicado: (2017)

Modulation of Allosteric Control and Evolution of Hemoglobin
por: Brunori, Maurizio, et al.
Publicado: (2023)

Non-covalent allosteric regulation of capsule catalysis
por: Martí-Centelles, Vicente, et al.
Publicado: (2020)

Molecular Mimics of Classic P-Glycoprotein Inhibitors as Multidrug Resistance Suppressors and Their Synergistic Effect on Paclitaxel
por: El-Araby, Moustafa E., et al.
Publicado: (2017)

Assessments of Alpha-Amylase Inhibitory Potential of Tagetes Flavonoids through In Vitro, Molecular Docking, and Molecular Dynamics Simulation Studies
por: Mohamed, Gamal A., et al.
Publicado: (2023)

Collective Dynamics Underlying Allosteric Transitions in Hemoglobin
por: Vesper, Martin D., et al.
Publicado: (2013)

Insight into the Allosteric Mechanism of Scapharca Dimeric Hemoglobin
por: Laine, Jennifer M., et al.
Publicado: (2014)

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
por: Quambusch, Lena, et al.
Publicado: (2019)

Systematic Analysis of Covalent and Allosteric Protein Kinase Inhibitors
por: Xerxa, Elena, et al.
Publicado: (2023)

Selective glycoprotein detection through covalent templating and allosteric click-imprinting
por: Stephenson-Brown, Alexander, et al.
Publicado: (2015)

Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt
por: Uhlenbrock, Niklas, et al.
Publicado: (2019)

Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme
por: Lv, Zongyang, et al.
Publicado: (2018)

Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
por: Doornbos, Maarten L. J., et al.
Publicado: (2018)

Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases
por: Andersen, Jacob Lauwring, et al.
Publicado: (2018)

Covalent Allosteric Inhibitors of Akt Generated Using a Click Fragment Approach
por: van der Westhuizen, Leandi, et al.
Publicado: (2022)

A Reverse Time-Course Method for Transcriptional Chase Analyses of mRNA Half-Lives in Cultured Cells
por: Abdulmalik, Osheiza, et al.
Publicado: (2012)

Identification and characterization of RBM12 as a novel regulator of fetal hemoglobin expression
por: Wakabayashi, Aoi, et al.
Publicado: (2022)

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
por: Kulkarni, Pushkar M., et al.
Publicado: (2015)

Modifying Caspase-3 Activity by Altering Allosteric Networks
por: Cade, Christine, et al.
Publicado: (2014)

The mechanism of formation, structure and physiological relevance of covalent hemoglobin attachment to the erythrocyte membrane
por: Welbourn, Elizabeth M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3m7l0am1m9ghscn16ke2i55sq1